United States · FDA National Drug Code directory

Xyzal Allergy 24HR

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
41167-3510_f43bc46c-c507-4ccf-9b93-17eaeebf4ed5
Product NDC
41167-3510
Form
TABLET
Composition / generic term
Levocetirizine dihydrochloride
Labeler
Chattem, Inc.
Marketing category
NDA
Marketing start / end (source format)
20170310
Source listing expiry
20271231

Source-listed ingredients

  • LEVOCETIRIZINE DIHYDROCHLORIDE — 5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 BLISTER PACK in 1 CARTON (41167-3510-0) / 10 TABLET in 1 BLISTER PACK · 41167-3510-0
  • 1 BOTTLE in 1 CARTON (41167-3510-1) / 35 TABLET in 1 BOTTLE · 41167-3510-1
  • 1 BOTTLE in 1 CARTON (41167-3510-2) / 55 TABLET in 1 BOTTLE · 41167-3510-2
  • 1 BOTTLE in 1 CARTON (41167-3510-3) / 80 TABLET in 1 BOTTLE · 41167-3510-3
  • 2 BOTTLE in 1 CARTON (41167-3510-4) / 55 TABLET in 1 BOTTLE · 41167-3510-4
  • 1 BOTTLE in 1 CARTON (41167-3510-5) / 45 TABLET in 1 BOTTLE · 41167-3510-5
  • 1 BLISTER PACK in 1 CARTON (41167-3510-6) / 5 TABLET in 1 BLISTER PACK · 41167-3510-6

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →